Sridhar Venkatesh

Sridhar Venkatesh's lobbying: the registrations they file and every meeting they've reported since November 2021.

Registrant (responsible officer)

General Manager and President

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament: 45
Since Nov 2021: 145
Active registrations: 0

Reported meetings

Jul 22, 2024 GlaxoSmithKline Inc.
- Fatima Asghar · Policy Advisor, Health Canada (HC)
- Ella Alvarado De Catleugh · Intern, Health Canada (HC)
Health

Official report
Jul 11, 2024 GlaxoSmithKline Inc.
- Ophelia John · Policy Advisor, Health Canada (HC)
Health

Official report
Jun 26, 2024 GlaxoSmithKline Inc.
- Judith Seidman · Senator, Senate of Canada
Health

Official report
Jun 25, 2024 GlaxoSmithKline Inc.
- Cid Cabillan · Policy Advisor, Immigration, Refugees and Citizenship Canada (IRCC)
Health

Official report
Jun 19, 2024 GlaxoSmithKline Inc.
- Mohamed-Iqbal Ravalia · Senator, Senate of Canada
Health

Official report
Jun 13, 2024 GlaxoSmithKline Inc.
- Tom Kmiec · Member of Parliament
Health

Official report
Jun 4, 2024 GlaxoSmithKline Inc.
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
- Caroline Menard · Manager, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealth

Official report
May 30, 2024 GlaxoSmithKline Inc.
- Joanna Lam · Policy Advisor, Indigenous Services Canada (ISC)
Health

Official report
May 17, 2024 GlaxoSmithKline Inc.
- Erin Henry · Director General, Public Health Agency of Canada (PHAC)
- Joel Denis · Director General, Public Health Agency of Canada (PHAC)
- Heather Deehan · Executive Director, Vaccine Distribution and Logistics, Public Health Agency of Canada (PHAC)
- Kelsey Young · Deputy Executive Secretary, Public Health Agency of Canada (PHAC)
Health

Official report
Apr 30, 2024 GlaxoSmithKline Inc.
- Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealth

Official report
Apr 16, 2024 GlaxoSmithKline Inc.
- Semhar Zerat · Director, Public Health Agency of Canada (PHAC)
Health

Official report
Apr 16, 2024 GlaxoSmithKline Inc.
- Jaxson Khan · Sr Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- Laurel Chester · Senior Advisor, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentGovernment ProcurementHealth

Official report
Apr 16, 2024 GlaxoSmithKline Inc.
- Colin Deacon · Senator, Senate of Canada
Economic Development

Official report
Apr 15, 2024 GlaxoSmithKline Inc.
- Francis Bilodeau · Associate Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Andrea Johnston · Assistant deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Etienne-Rene Massie · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealthResearch and Development

Official report
Apr 15, 2024 GlaxoSmithKline Inc.
- Mark Schaan · Senior Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Economic DevelopmentHealthResearch and Development

Official report
Apr 4, 2024 GlaxoSmithKline Inc.
- Joel Denis · Director General, Public Health Agency of Canada (PHAC)
Health

Official report
Mar 15, 2024 GlaxoSmithKline Inc.
- Anita Anand · President of the Treasury Board, Treasury Board Of Canada Secretariat (TBS)
BudgetHealth

Official report
Feb 13, 2024 GlaxoSmithKline Inc.
- Qasir Hanif · Director of Stakeholder Relations, Global Affairs Canada (GAC)
- Aram Shoujounian · Policy Advisor, Global Affairs Canada (GAC)
- Matthew Trnkus · Senior Advisor, Global Affairs Canada (GAC)
Health

Official report
Feb 13, 2024 GlaxoSmithKline Inc.
- Ophelia John · Policy Advisor, Health Canada (HC)
- Eshan Naik · Director of Policy, Health Canada (HC)
Health

Official report
Jan 26, 2024 GlaxoSmithKline Inc.
- Paul Moen · Chief of Staff, Employment and Social Development Canada (ESDC)
- Lhori Webster · Director of Policy, Employment and Social Development Canada (ESDC)
Health

Official report
Jan 22, 2024 GlaxoSmithKline Inc.
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Economic Development

Official report
Jan 16, 2024 GlaxoSmithKline Inc.
- Victor Kandasamy · Policy Advisor, Public Services and Procurement Canada (PSPC)
Government Procurement

Official report
Jan 9, 2024 GlaxoSmithKline Inc.
- Ophelia John · Policy Advisor, Health Canada (HC)
Government ProcurementHealth

Official report
Dec 14, 2023 GlaxoSmithKline Inc.
- Laurel Chester · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Economic Development

Official report
Dec 13, 2023 GlaxoSmithKline Inc.
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Economic Development

Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.